Navigation Links
HIV Drug Combo May Help Prevent Malaria Reinfection
Date:11/28/2012

WEDNESDAY, Nov. 28 (HealthDay News) -- Treatment with a combination of certain HIV drugs greatly reduces the risk of recurrent malaria in children with HIV who are also being treated with drugs to prevent the mosquito-borne infection, according to new research.

The study included more than 170 HIV-positive infants and children up to 6 years old in Uganda who were receiving anti-malarial drugs and HIV treatment, including either a combination of the protease inhibitors lopinavir and ritonavir, or a class of drugs called non-nucleoside reverse transcriptase inhibitors (NNRTIs).

Despite the anti-malarial drugs and other preventive measures -- such as mosquito nets -- the children's risk of developing malaria during their first six months of HIV treatment was more than 40 percent. The risk during that time period was about the same whether the children were taking the protease inhibitors or an NNRTI, the investigators found.

However, among children who developed malaria and were successfully treated for it, 41 percent of those taking an NNRTI had a recurrence of malaria within 28 days compared with 14 percent of those taking the protease inhibitors.

And after 63 days, malaria recurrence had occurred among 54 percent of those taking an NNRTI and 28 percent of those taking the protease inhibitors, the research showed.

Blood levels of anti-malarial drugs in children taking the protease inhibitors were higher than in those taking an NNRTI, the researchers said.

The study, published Nov. 29 in the New England Journal of Medicine, was funded by the U.S. National Institute of Child Health and Human Development.

"It's possible that these protease inhibitors prevent anti-malarial drugs from breaking down or have some other additive effect against the malarial parasite," Dr. Lynne Mofenson, chief of the Pediatric, Adolescent, and Maternal AIDS Branch at the NICHD, said in an institute news release.

"Laboratory studies also suggest that protease inhibitors can block the malaria parasite outright. Finding out why this drug combination is effective is an area for further study," she added.

More information

The U.S. National Institute of Allergy and Infectious Diseases has more about malaria.

-- Robert Preidt

SOURCE: U.S. National Institute of Child Health and Human Development, news release, Nov. 28, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Being neurotic, and conscientious, a good combo for health
2. PI3-kinase and PARP inhibitor combo may offer new treatment option for triple-neg breast cancers
3. Cooking-Oil Combo May Improve Blood Pressure
4. Double drug combo could shut down abnormal blood vessel growth that feeds disease
5. Drug combo better for common type of metastatic breast cancer, UCI-led study finds
6. Booze, Energy Drinks, Casual Sex Combo Common in College: Study
7. FDA Approves Combo Shot for Meningitis, Hib in Kids
8. Combo Therapy May Help Ease Ringing in the Ears
9. Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy
10. Two-Drug Combo May Be Safe for Melanoma Treatment
11. Two-Drug Combo Helps Teens With Migraines
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HIV Drug Combo May Help Prevent Malaria Reinfection
(Date:7/21/2017)... NEW ORLEANS, La. (PRWEB) , ... July 21, ... ... tool to allow 4th-year medical students improve their chances of acceptance to a ... particularly for those who have earned degrees outside the U.S. , According to ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... ligament (ACL) offer patients improved quality of life five years after injury, according ... Annual Meeting in Toronto, Ontario, Canada. The study followed patients for five ...
(Date:7/20/2017)... July 20, 2017 (PRWEB) , ... ... ... Technologies, a global provider of enterprise-grade IT operations analytics and application performance ... of one of world’s largest healthcare services providers. , According to Peter ...
(Date:7/20/2017)... ... , ... Doctors on Liens, the leading network of medical providers working on ... Dr. Russell Horine, DC to their exclusive list of medical professionals. Horine Chiropractic is ... as the clinic director and his son Dr. Lee Horine and daughter-in-law Dr. Natalie ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... two products that further expand its existing adherence automation lines. The ATP® Mini ... mirror the advanced technology of TCG’s standard products, but at a size and ...
Breaking Medicine News(10 mins):
(Date:6/30/2017)... 2017  AVACEN Medical (AVACEN) announced the publication of new research ... use of its AVACEN Treatment Method to significantly reduce ... ... Medical ... It affects approximately 200 to 400 million people worldwide according to ...
(Date:6/27/2017)... , June 27, 2017  Therapix Biosciences Ltd. ... pharmaceutical company specializing in the development of cannabinoid-based drugs, ... Stock Market Opening Bell in New York, ... honor of its initial public offering (IPO) of American ... in March 2017. Dr. Elran Haber, Ph.D., ...
(Date:6/20/2017)... and LAGUNA HILLS, Calif. , ... of new data that validate the use of MMprofiler ... patients with multiple myeloma (MM). In a poster presentation ... Hematology Association (EHA) in Madrid, Spain ... MMprofiler for identifying high-risk elderly patients. ...
Breaking Medicine Technology: